ApprovedVitamin
011220 NIACINAMIDE 2% / SPIRONOLACTONE 5% / TRETINOIN 0.05%
Formula Pending
Molecular Mass
N/A
CAS Registry
N/A
Risk Class
LOW
Last Audit
Jan 1, 2024
Research Abstract
Vitamin medication
011220 NIACINAMIDE 2% / SPIRONOLACTONE 5% / TRETINOIN 0.05% is a vitamin asset inside marketed initiatives, optimized for therapeutic and clinical research.
The dossier currently sits in approved with a low risk rating, meaning it is cleared for baseline monitoring protocols.
Supply records cite CAS N/A with updates logged 2024-01-01.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
TherapeuticClinical Research
Nomenclature
011220 NIACINAMIDE 2% / SPIRONOLACTONE 5% / TRETINOIN 0.05%
Reference Material
- [1] Anubis Compound Registry • CAS N/A
- [2] Operations Pulse • Marketed
- [3] Risk Governance Ledger • LOW clearance for 011220-NIACINAMIDE-2-SPIRONOLACTONE-5-TRETINOIN-0-05